• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复方磺胺甲恶唑浓溶液的稳定性。

Stability of concentrated trimethoprim-sulfamethoxazole admixtures.

作者信息

Jarosinski P F, Kennedy P E, Gallelli J F

机构信息

Department of Pharmacy, NIH, Bethesda, MD 20892.

出版信息

Am J Hosp Pharm. 1989 Apr;46(4):732-7.

PMID:2785757
Abstract

The stability of trimethoprim-sulfamethoxazole (TMP-SMX) at various concentrations in 5% dextrose injection or 0.9% sodium chloride injection was studied. Appropriate volumes of TMP-SMX formulation (80 mg TMP and 400 mg SMX/5 mL) were mixed with 5% dextrose injection or 0.9% sodium chloride injection to provide dilutions of 1:25 v/v, 1:20 v/v, 1:15 v/v, and 1:10 v/v. Aliquots were removed at 0, 0.5, 1, 2, 4, 8, 14, 24, and 48 hours and filtered. The pH of the samples was determined, and the samples were assayed for trimethoprim and sulfamethoxazole content by high-performance liquid chromatography. Admixtures were visually inspected for precipitate before each sample was removed. The concentration of SMX in all admixtures did not change during the study period. The stability of TMP was dependent on concentration and vehicle. At a 1:25 v/v dilution, TMP was stable for 48 hours in 5% dextrose injection and 0.9% sodium chloride injection. At a 1:20 v/v dilution, TMP was stable for 24 hours in 5% dextrose injection and 14 hours in 0.9% sodium chloride injection. At a 1:15 v/v dilution, TMP was stable for four hours in 5% dextrose injection and two hours in 0.9% sodium chloride injection. At a 1:10 v/v dilution, TMP was stable for one hour in 5% dextrose injection and 0.9% sodium chloride injection. Concentrated solutions of TMP-SMX should be prepared in 5% dextrose injection, infused within one hour of preparation, and visually inspected for precipitation before and during infusion.

摘要

研究了甲氧苄啶-磺胺甲恶唑(TMP-SMX)在5%葡萄糖注射液或0.9%氯化钠注射液中不同浓度下的稳定性。将适量体积的TMP-SMX制剂(80mg TMP和400mg SMX/5mL)与5%葡萄糖注射液或0.9%氯化钠注射液混合,制成1:25 v/v、1:20 v/v、1:15 v/v和1:10 v/v的稀释液。在0、0.5、1、2、4、8、14、24和48小时取出等分试样并过滤。测定样品的pH值,并通过高效液相色谱法测定样品中甲氧苄啶和磺胺甲恶唑的含量。在每次取出样品之前,对混合物进行目视检查是否有沉淀。在研究期间,所有混合物中SMX的浓度均未发生变化。TMP的稳定性取决于浓度和溶媒。在1:25 v/v稀释度下,TMP在5%葡萄糖注射液和0.9%氯化钠注射液中稳定48小时。在1:20 v/v稀释度下,TMP在5%葡萄糖注射液中稳定24小时,在0.9%氯化钠注射液中稳定14小时。在1:15 v/v稀释度下,TMP在5%葡萄糖注射液中稳定4小时,在0.9%氯化钠注射液中稳定2小时。在1:10 v/v稀释度下,TMP在5%葡萄糖注射液和0.9%氯化钠注射液中稳定1小时。TMP-SMX浓缩溶液应在5%葡萄糖注射液中配制,在配制后1小时内输注,并在输注前和输注期间目视检查是否有沉淀。

相似文献

1
Stability of concentrated trimethoprim-sulfamethoxazole admixtures.复方磺胺甲恶唑浓溶液的稳定性。
Am J Hosp Pharm. 1989 Apr;46(4):732-7.
2
Stability of trimethoprim-sulfamethoxazole injection in two infusion fluids.甲氧苄啶-磺胺甲恶唑注射液在两种输液中的稳定性
Am J Hosp Pharm. 1981 Jul;38(7):1004-6.
3
Stability of trimethoprim-sulfamethoxazole injection in five infusion fluids.甲氧苄啶-磺胺甲恶唑注射液在五种输液中的稳定性
Am J Hosp Pharm. 1982 Oct;39(10):1681-4.
4
Solubilities of trimethoprim and sulfamethoxazole at various pH values and crystallization of trimethoprim from infusion fluids.甲氧苄啶和磺胺甲恶唑在不同pH值下的溶解度以及甲氧苄啶在输液中的结晶情况。
J Parenter Sci Technol. 1991 May-Jun;45(3):147-51.
5
High-performance liquid chromatography method for the simultaneous determination of sulfamethoxazole and trimethoprim in bovine milk using an on-line clean-up column.使用在线净化柱同时测定牛乳中磺胺甲恶唑和甲氧苄啶的高效液相色谱法
J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Nov 5;826(1-2):139-46. doi: 10.1016/j.jchromb.2005.08.006. Epub 2005 Oct 5.
6
Stability of ranitidine hydrochloride at dilute concentration in intravenous infusion fluids at room temperature.盐酸雷尼替丁在室温下于静脉输液中稀浓度时的稳定性。
Am J Hosp Pharm. 1990 Jul;47(7):1580-4.
7
Stability of pentamidine isethionate in 5% dextrose and 0.9% sodium chloride injections.喷他脒异硫氰酸盐在5%葡萄糖注射液和0.9%氯化钠注射液中的稳定性。
Am J Hosp Pharm. 1986 Jun;43(6):1486-8.
8
Osmolality of small-volume i.v. admixtures for pediatric patients.儿科患者小容量静脉内混合液的渗透压摩尔浓度
Am J Hosp Pharm. 1990 Jun;47(6):1359-64.
9
Compatibility of aminophylline and methylprednisolone sodium succinate intravenous admixtures.氨茶碱与甲泼尼龙琥珀酸钠静脉混合液的配伍性
Am J Hosp Pharm. 1986 Jun;43(6):1482-5.
10
Stability and compatibility of methylprednisolone sodium succinate and cimetidine hydrochloride in 5% dextrose injection.琥珀酸甲泼尼龙与盐酸西咪替丁在5%葡萄糖注射液中的稳定性及配伍性
Am J Hosp Pharm. 1991 Jun;48(6):1237-41.

引用本文的文献

1
Use of Extracorporeal Membrane Oxygenation in Pneumonia of an Infant with AIDS.体外膜肺氧合在一名患艾滋病婴儿肺炎中的应用
Case Rep Pediatr. 2020 Nov 18;2020:8840131. doi: 10.1155/2020/8840131. eCollection 2020.
2
Investigations into the physical and chemical stability of concentrated co-trimoxazole intravenous infusions.复方磺胺甲恶唑静脉输注浓溶液的物理和化学稳定性研究。
Eur J Hosp Pharm. 2018 Oct;25(e2):e102-e108. doi: 10.1136/ejhpharm-2017-001225. Epub 2017 Jul 19.